New approaches for the treatment of genomic damage in end-stage renal disease.

J Ren Nutr

Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany.

Published: January 2008

Objective: Patients with end-stage renal disease (ESRD) exhibit an enhanced genomic damage which may have pathophysiological relevance for cancer development and cardiovascular complications. The DNA damage has been shown both in the pre-dialysis and dialysis phase by micronucleus (MN) frequency test and single cell gel electrophoresis in peripheral blood lymphocytes (PBLs). A major cause of DNA damage is oxidative stress, which may be induced by various uremic toxins, including advanced glycation end products (AGEs), as well as by activation of the renin-angiotensin system.

Results: Genomic damage of ESRD patients can be ameliorated by daily hemodialysis (DHD), as observed in a cross-sectional study. Patients on DHD showed a reduced genomic damage in the MN frequency test in PBLs compared to those treated with standard hemodialysis. Another way to decrease DNA damage in ESRF seems to be the chronic administration of angiotensin II type 1 (AT)1 receptor blockers. In 15 maintenance hemodialysis patients, treatment with candesartan resulted in a significant improvement of DNA damage. According to our in vitro data, these beneficial effects may be a consequence of preventing the genotoxic actions of angiotensin II. Vitamin B1 (benfotiamine) was found to be able to reduce the amount of circulating AGEs in animal experiments. We could show in a pilot study that the application of benfotiamine significantly reduced the genomic damage of dialysis patients.

Conclusion: There are several possibilities of lowering genomic damage in dialysis patients, which in the long run might lead to lower cancer incidences.

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.jrn.2007.10.026DOI Listing

Publication Analysis

Top Keywords

genomic damage
24
dna damage
16
damage
10
end-stage renal
8
renal disease
8
frequency test
8
reduced genomic
8
damage dialysis
8
genomic
6
patients
5

Similar Publications

DNA damage triggers heritable alterations in DNA methylation patterns in Arabidopsis.

Mol Plant

January 2025

State Key Laboratory of Wheat Improvement, School of Advanced Agricultural Sciences, Peking University, Beijing 100871, China; Beijing Life Science Academy, Beijing 102299, China. Electronic address:

It has been hypothesized that DNA damage has the potential to induce DNA hypermethylation, contributing to carcinogenesis in mammals. However, there is no sufficient evidence to support that DNA damage can cause genome-wide DNA hypermethylation. Here, we demonstrated that DNA single-strand breaks with 3'-blocked ends (DNA 3'-blocks) can not only reinforce DNA methylation at normally methylated loci but also can induce DNA methylation at normally nonmethylated loci in plants.

View Article and Find Full Text PDF

CHD6 has poly(ADP-ribose)- and DNA-binding domains and regulates PARP1/2-trapping inhibitor sensitivity via abasic site repair.

Nat Commun

January 2025

Robson DNA Science Centre, Charbonneau Cancer Institute, Department of Biochemistry & Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

To tolerate oxidative stress, cells enable DNA repair responses often sensitive to poly(ADP-ribose) (PAR) polymerase 1 and 2 (PARP1/2) inhibition-an intervention effective against cancers lacking BRCA1/2. Here, we demonstrate that mutating the CHD6 chromatin remodeler sensitizes cells to PARP1/2 inhibitors in a manner distinct from BRCA1, and that CHD6 recruitment to DNA damage requires cooperation between PAR- and DNA-binding domains essential for nucleosome sliding activity. CHD6 displays direct PAR-binding, interacts with PARP-1 and other PAR-associated proteins, and combined DNA- and PAR-binding loss eliminates CHD6 relocalization to DNA damage.

View Article and Find Full Text PDF

Immune checkpoint inhibitor (ICI) therapy is a cornerstone treatment for many cancers, but it can induce severe immunotoxicity, including acute interstitial nephritis (AIN). Currently, kidney biopsy is required to differentiate ICI-AIN from other causes of acute kidney injury (AKI). However, this invasive approach can lead to morbidity, delayed glucocorticoid treatment for patients with AIN, and unnecessarily prolonged suspension of ICI therapy in non-AIN patients.

View Article and Find Full Text PDF

Salt stress severely affects the growth and development of tomato. Strigolactones (SLs) and DNA methylation have been shown to be involved in the growth and development and response to salt stress in tomato. However, the regulation of SLs on DNA methylation in tomato under salt stress remains unclear.

View Article and Find Full Text PDF

Plants deploy cellular Ca2+ elevation as a signal for environmental stress signaling. Extracellular ATP (eATP) is released into the extracellular matrix when cells are wounded. DOES NOT RESPOND TO NUCLEOTIDES 1 (DORN1), a key legume-type lectin receptor, senses and binds eATP and activates Ca2+ signaling.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!